BR112023002900A2 - Peptídeo para aplicações terapêuticas no campo dermatológico - Google Patents
Peptídeo para aplicações terapêuticas no campo dermatológicoInfo
- Publication number
- BR112023002900A2 BR112023002900A2 BR112023002900A BR112023002900A BR112023002900A2 BR 112023002900 A2 BR112023002900 A2 BR 112023002900A2 BR 112023002900 A BR112023002900 A BR 112023002900A BR 112023002900 A BR112023002900 A BR 112023002900A BR 112023002900 A2 BR112023002900 A2 BR 112023002900A2
- Authority
- BR
- Brazil
- Prior art keywords
- peptide
- therapeutic applications
- sequence
- dermatological field
- skin
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 206010040829 Skin discolouration Diseases 0.000 abstract 1
- 230000002638 denervation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000030214 innervation Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000019612 pigmentation Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
peptídeo para aplicações terapêuticas no campo dermatológico. a presente invenção refere-se a um peptídeo de 14 aminoácidos tendo a sequência id no. 1 ou peptídeo de até 16 aminoácidos tendo uma sequência com pelo menos 85%, preferivelmente pelo menos 90% e, preferivelmente, pelo menos 95%, de identidade tendo a sequência id no. 1, ou um derivado e/ou sal do mesmo, capaz de promover pigmentação e/ou inervação da pele em discromia e/ou doenças de desnervação da pele. uma composição farmacêutica compreendendo tal peptídeo e pelo menos um excipiente farmaceuticamente aceitável são um objeto adicional da invenção.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102020000020287A IT202000020287A1 (it) | 2020-08-20 | 2020-08-20 | Peptide per applicazioni terapeutiche in campo dermatologico |
| PCT/IB2021/057631 WO2022038555A1 (en) | 2020-08-20 | 2021-08-19 | Peptide for therapeutic applications in the dermatological field |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023002900A2 true BR112023002900A2 (pt) | 2024-03-12 |
Family
ID=73038333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023002900A BR112023002900A2 (pt) | 2020-08-20 | 2021-08-19 | Peptídeo para aplicações terapêuticas no campo dermatológico |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230355713A1 (pt) |
| EP (1) | EP4199952A1 (pt) |
| JP (1) | JP2023539730A (pt) |
| CN (1) | CN116669695A (pt) |
| AU (1) | AU2021328761A1 (pt) |
| BR (1) | BR112023002900A2 (pt) |
| CA (1) | CA3191912A1 (pt) |
| IL (1) | IL300512A (pt) |
| IT (1) | IT202000020287A1 (pt) |
| WO (1) | WO2022038555A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024000088A1 (zh) * | 2022-06-27 | 2024-01-04 | 欧诗漫生物股份有限公司 | 一种珍珠来源美白多肽及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100467057C (zh) * | 2003-12-30 | 2009-03-11 | 中国医科大学 | 神经生长因子外用药剂及其制备方法 |
| ME00226B (me) * | 2004-07-15 | 2011-02-10 | Medarex Llc | Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade |
| ITRM20110574A1 (it) | 2011-11-02 | 2013-05-03 | Sampo S R L | Preparato topico per indurre la pigmentazione cutanea e per il trattamento di discromie cutanee e vitiligine. |
| IT201800009384A1 (it) * | 2018-10-11 | 2020-04-11 | Cosmo Srl | Peptide for cosmetic application |
-
2020
- 2020-08-20 IT IT102020000020287A patent/IT202000020287A1/it unknown
-
2021
- 2021-08-19 CA CA3191912A patent/CA3191912A1/en active Pending
- 2021-08-19 EP EP21759162.7A patent/EP4199952A1/en active Pending
- 2021-08-19 US US18/021,979 patent/US20230355713A1/en active Pending
- 2021-08-19 AU AU2021328761A patent/AU2021328761A1/en active Pending
- 2021-08-19 BR BR112023002900A patent/BR112023002900A2/pt unknown
- 2021-08-19 IL IL300512A patent/IL300512A/en unknown
- 2021-08-19 WO PCT/IB2021/057631 patent/WO2022038555A1/en active Application Filing
- 2021-08-19 JP JP2023512269A patent/JP2023539730A/ja active Pending
- 2021-08-19 CN CN202180050807.4A patent/CN116669695A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022038555A1 (en) | 2022-02-24 |
| US20230355713A1 (en) | 2023-11-09 |
| AU2021328761A1 (en) | 2023-03-16 |
| EP4199952A1 (en) | 2023-06-28 |
| JP2023539730A (ja) | 2023-09-19 |
| CN116669695A (zh) | 2023-08-29 |
| IT202000020287A1 (it) | 2022-02-20 |
| IL300512A (en) | 2023-04-01 |
| CA3191912A1 (en) | 2022-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023229550A1 (en) | Injectable botulinum toxin formulations | |
| US8449879B2 (en) | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same | |
| Alencar-Silva et al. | Breaking the frontiers of cosmetology with antimicrobial peptides | |
| US20190300583A1 (en) | Neurotoxins for use in inhibiting cgrp | |
| BR112016003358A2 (pt) | método para aumentar a expressão de proteínas codificadas por rna | |
| NZ600499A (en) | Hatching fluid enzymes and uses thereof | |
| US10925922B2 (en) | Growth promoting peptides, and uses thereof | |
| US20190284248A1 (en) | Peptides, and uses thereof | |
| BR112023002900A2 (pt) | Peptídeo para aplicações terapêuticas no campo dermatológico | |
| Hilchie et al. | Enhanced killing of breast cancer cells by a d-amino acid analog of the winter flounder-derived pleurocidin NRC-03 | |
| ES2604707T3 (es) | Composición farmacéutica para su uso en el tratamiento de cicatrices en la piel | |
| WO2017009488A1 (en) | Topical compositions | |
| JP6900324B2 (ja) | 抗微生物ペプチド | |
| ATE505199T1 (de) | Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser | |
| KR101824450B1 (ko) | 히알루로니다제를 포함한 지방분해 및 보톡스 기능이 강화된 약물 키트 | |
| KR20210093748A (ko) | 흉터형성을 최소화하는 데에 사용하기 위한 신경독소 | |
| CN113318222B (zh) | 超氧化物歧化酶在制备治疗银屑病药物中的应用及方法 | |
| BR0109279A (pt) | Antagonistas de lhrh, sua preparação e aplicação como medicamento | |
| KR102091567B1 (ko) | 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물 | |
| ES2884787T3 (es) | Uso de derivados de ramnosa como agentes antifúngicos | |
| BR112022027124A2 (pt) | Formulações para promover a hidratação e métodos de uso das mesmas | |
| BR112021016795A8 (pt) | Administração de inibidor de enzima de ativação de sumo e inibidores de checkpoint | |
| JP6840086B2 (ja) | 薬物として、特に皮膚炎症性疾患において使用するためのフィブリノゲン由来の単離されたペプチドおよびそれらのフラグメント | |
| US11236138B2 (en) | Peptide, method and composition for melanin polymerization and hair darkening | |
| BR112022001729A2 (pt) | Peptídeo ou um sal farmacêutica ou cosmeticamente aceitável do mesmo, composição farmacêutica ou cosmética, e, composições despigmentante e pigmentante |